[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365782-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365782-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","entr1-affects-the-progression-of-colon-cancer-by-regulating-energy-metabolism-under-the-influence-of-glycolysis","ENTR1 affects the progression of colon cancer by regulating energy metabolism under the influence of glycolysis","","Endosome-associated trafficking regulator 1 (ENTR1), also known as SDCCAG3, was investigated for its role in colon cancer progression through energy metabolism and glycolysis. ENTR1 expression was assessed in normal and tumor tissues using clinical data from multiple databases, followed by Mendelian randomization analyses. In vitro experiments tested ENTR1’s impact on colon cancer proliferation and glycolysis. Results show ENTR1 upregulation across most tumors, with genetic evidence supporting a causal relationship. Cellular knockouts reduced HCT-116 proliferation and downregulated glycolytic enzymes, suggesting a therapy-relevant target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/entr1-affects-the-progression-of-colon-cancer-by-regulating-energy-metabolism-under-the-influence-of-glycolysis/365782/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/entr1-affects-the-progression-of-colon-cancer-by-regulating-energy-metabolism-under-the-influence-of-glycolysis/365782.png","ImageObject",300,407,{"name":42,"@type":43},"Riley West","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is ENTR1 and why is it relevant to colon cancer?","Question",{"text":63,"@type":64},"ENTR1, also called SDCCAG3, regulates protein transport and was previously linked to tumor growth in preliminary studies. This work focuses on how ENTR1 may drive colon cancer progression via energy metabolism and glycolysis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study evaluate the relationship between ENTR1 and colon cancer?",{"text":68,"@type":64},"The study analyzed ENTR1 expression in normal and tumor tissues using clinical data from multiple databases. It further applied Mendelian randomization approaches, including summary-data-based Mendelian randomization.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental evidence supports ENTR1’s role in tumor growth and glycolysis?",{"text":72,"@type":64},"Cellular experiments showed that knocking out ENTR1 reduced proliferation of HCT-116 colon cancer cells and lowered the expression of key glycolytic enzymes, consistent with ENTR1 regulating glycolysis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365782,1790301191,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Ma etal. BMC Cancer (2025) 25:992  \n[https://doi.org/10.1186/s12885-025-14412-5](https://doi.org/10.1186/s12885-025-14412-5)  \nBMC Cancer  \n RESEARCH Open Access  \nENTR1 affects the progression of colon cancer by regulating energy metabolism under the influence of glycolysis  \nAnquan Ma1†, Chuanyao Zhai1†, Qixuan He1, Wenhao Wang1, Huiping Ren1, Kai Mao1, Weipeng Lan 1 and Jing Lan 1*  \nAbstract  \nBackground Endosome-associated trafficking regulator 1 (ENTR1), also known as Serologically Defined Colon Cancer Antigen 3 (SDCCAG3), was initially identified in colon cancer and plays a crucial role in protein transport. Preliminary studies indicate that ENTR1 is involved in the growth of certain tumor types.  \nMethods In this study, we analyzed ENTR1 expression levels in normal and tumor tissues using clinical sample data from multiple databases. We also employed Mendelian randomization (MR) analysis of ENTR1 . Finally, we conducted in vitro experiments to validate the effects of ENTR1 on colon cancer proliferation and glycolysis.  \nResults Our findings reveal that ENTR1 is upregulated in most tumors. Summary-data-based Mendelian Randomization (SMR) analysis indicates a causal relationship between ENTR1 and colon cancer. Further machine learning and metabolite-based Mendelian randomization suggest that ENTR1 may influence tumor growth by regulating glycolysis. Further cellular experiments confirm that knocking out ENTR1 reduces the proliferation of HCT-116 cells and downregulates the expression levels of key glycolytic enzymes.  \nConclusions This study uncovers the role of ENTR1 in various cancers and demonstrates that ENTR1 may promote colon cancer growth by regulating glycolysis, providing a new target for cancer therapy.  \nKeywords ENTR1, Colon cancer, Glycolysis  \n†Anquan Ma and Chuanyao Zhai contributed equally to this work and should be considered as co-first author.  \n*Correspondence: Jing Lan [lanjing@sdu.edu.cn](lanjing@sdu.edu.cn)  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nMa etal. BMC Cancer (2025) 25:992 Page 2 of 24  \nGraphical Abstract  \nIntroduction  \nColon cancer is a common malignant tumor of the digestive system with a high mortality rate, posing a significant threat to human health [1]. The abnormal increase in glycolysis levels in colon cancer is a significant factor that promotes tumor progression [2]. In addition to metabolic reprogramming, the pathogenesis of colon cancer involves a complex interplay of genetic mutations, epigenetic alterations, and dysregulated signaling pathways. Key driver mutations in genes such as APC, KRAS, and PIK3CA initiate and promote tumorigenesis through dysregulation of the Wnt/β-catenin, MAPK, and PI3K/ AKT pathways [3–6]. Moreover, inflammation-induced changes in the tumor microenvironment and interactions with immune cells further contribute to disease progression [7]. Understanding t","cbCaiiCQHXeVlm6o","https://ap.wps.com/l/cbCaiiCQHXeVlm6o","pdf",18970335,24,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Graphical Abstract\n# Introduction","[{\"question\":\"What is ENTR1 and why is it relevant to colon cancer?\",\"answer\":\"ENTR1, also called SDCCAG3, regulates protein transport and was previously linked to tumor growth in preliminary studies. This work focuses on how ENTR1 may drive colon cancer progression via energy metabolism and glycolysis.\"},{\"question\":\"How did the study evaluate the relationship between ENTR1 and colon cancer?\",\"answer\":\"The study analyzed ENTR1 expression in normal and tumor tissues using clinical data from multiple databases. It further applied Mendelian randomization approaches, including summary-data-based Mendelian randomization.\"},{\"question\":\"What experimental evidence supports ENTR1’s role in tumor growth and glycolysis?\",\"answer\":\"Cellular experiments showed that knocking out ENTR1 reduced proliferation of HCT-116 colon cancer cells and lowered the expression of key glycolytic enzymes, consistent with ENTR1 regulating glycolysis.\"}]","ENTR1 affects the progression of colon cancer by regulating energy metabolism under the influence of glycolysis | PDF",1790162322,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34f8bc9ac28fe69d46ffd1315c6f6177.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57fa5ac5217eb9979da8e36018744079.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38ab8d3625054a4f7d5037840076d7aa.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc079c84462d39c407e36af15f69a53a.webp",980,1301]